No records
|
295 |
35759266900 |
Jacub Pandelaki |
Dr. dr. Jacub Pandelaki, Sp.Rad.(K) |
Departemen Radiologi |
Radiologi (Sp-1) |
Internet addiction in adolescents: Development and validation of Internet Addiction Diagnostic Questionnaire (KDAI) |
Siste K., Wiguna T., Bardasono S., Sekartini R., Pandelaki J., Sarasvita R., Suwartono C., Murtani B.J., Damayanti R., Christian H., Sen L.T., Nasrun M.W. |
Psychiatry Research |
|
Q1 |
|
|
No records
|
105 |
36056341600 |
Dante Saksono Harbuwono |
dr. Dante Saksono Harbuwono, Sp.PD., Ph.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Impact of Sodium Butyrate Treatment in LPS-Stimulated Peripheral Blood Mononuclear Cells of Poorly Controlled Type 2 DM |
Wibowo H., Harbuwono D.S., Tahapary D.L., Kartika R., Pradipta S., Larasati R.A. |
Frontiers in Endocrinology |
|
Q1 |
|
|
176 |
36056341600 |
Dante Saksono Harbuwono |
dr. Dante Saksono Harbuwono, Sp.PD., Ph.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia |
Yunir E., Tahapary D.L., Tarigan T.J.E., Harbuwono D.S., Oktavianda Y.D., Kristanti M., Iswati E., Sarumpaet A., Soewondo P. |
Journal of Diabetes and Metabolic Disorders |
|
Q2 |
|
|
220 |
36056341600 |
Dante Saksono Harbuwono |
dr. Dante Saksono Harbuwono, Sp.PD., Ph.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
The impact of Ramadan fasting on Fetuin-A level in type 2 diabetes mellitus |
Harbuwono D.S., Sazli B.I., Kurniawan F., Darmowidjojo B., Koesnoe S., Tahapary D.L. |
Heliyon |
|
Q1 |
|
|
530 |
36056341600 |
Dante Saksono Harbuwono |
dr. Dante Saksono Harbuwono, Sp.PD., Ph.D. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-2) |
ADA Diabetes Risk Test Adaptation in Indonesian Adult Populations: Can It Replace Random Blood Glucose Screening Test? |
Harbuwono D.S., Mokoagow M.I., Magfira N., Helda H. |
Journal of Primary Care and Community Health |
|
Q2 |
|
|
No records
|
176 |
36057746500 |
Tri Juli Edi Tarigan |
dr. Tri Juli Edi Tarigan, Sp.P.D.(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia |
Yunir E., Tahapary D.L., Tarigan T.J.E., Harbuwono D.S., Oktavianda Y.D., Kristanti M., Iswati E., Sarumpaet A., Soewondo P. |
Journal of Diabetes and Metabolic Disorders |
|
Q2 |
|
|
257 |
36057746500 |
Tri Juli Edi Tarigan |
dr. Tri Juli Edi Tarigan, Sp.P.D.(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Giant Recurrence Pituitary Adenoma After Three Times Transphenoidal Removal Surgery, One Craniotomy Procedure, and 30 Doses of External Radiotherapy |
Pramono L.A., Yunir E., Tarigan T.J.E., Nusanti S., Aman R.A., Suroyo I. |
Acta medica Indonesiana |
|
Q3 |
|
|
630 |
36057746500 |
Tri Juli Edi Tarigan |
dr. Tri Juli Edi Tarigan, Sp.P.D.(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Immunogenicity and efficacy of insulin glargine biosimilar ezelin versus originator insulin glargine in patients with type 2 diabetes |
Tarigan T.J.E., Dwijayanti A., Setyowati S., Louisa M. |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy |
|
Q2 |
|
|
No records
|
55 |
36058523500 |
Triya Damayanti |
dr. Triya Damayanti, Sp.P., Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
1 |
Q1 |
|
|
No records
|
55 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
1 |
Q1 |
|
|